Diagnos wins Health Canada licence for CARA retinal AI system

The Class II medical device authorization clears commercialization in Canada and supports service delivery to IRIS The Visual Group as the company also pursues approvals in Saudi Arabia and the U.S.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.